4AB
AbbVie, Inc. · GETTEX:4AB
263.60 EUR−0.6000 −0.23%
AbbVie, Inc. (GETTEX:4AB) last traded at 263.60 EUR, down 0.23% on the day. Over the past year the stock is up 34.90%. Its 52-week range is 163.42 to 270.25. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open263.90
Day range263.60 – 263.95
52-week range163.42 – 270.25
Volume17
Average volume (10 days)256
Market cap (USD)521.11 B
P/E51.33
EPS (TTM) (USD)5.82
Dividend yield2.32%
Beta (1 year)0.0129
Revenue (TTM) (USD)66.01 B
Employees57.00 K
Performance
+3.27%1 week
+13.84%1 month
+23.29%3 months
+50.34%6 months
+35.60%Year to date
+34.90%1 year
Technical rating
Buy
Daily summary of 11 oscillators and 15 moving averages. See every indicator
Analysts’ target
269.53 EUR
The average 1-year price target, +2.25% from the last price. See the forecast
Latest headlines
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
- What AbbVie (ABBV) Said on Its Q3 Earnings CallMarketBeat · 30 Oct 2026
- AbbVie Raises 2026 Outlook, Boosts DividendBenzinga · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. For study only, not investment advice.